Quick Summary
Covering the latest research from top Wall Street investment banks

AT&S Guidance Upgrade Reinforces ABF Shortage and Price-Hike Thesis, with Clearer Benefits for NYPCB and Kinsus

Institution
Goldman Sachs
Date
2026-08-06
Authors
Chao Wang、Allen Chang、Al Wang
Company
NYPCB、Kinsus、Unimicron Technology
Ticker
8046.TW、3189.TW、3037.TW
Industry
PCB and IC Substrates
Rating
NYPCB: Buy and on the Conviction List; Kinsus: Buy; Unimicron Technology: Neutral
BullishLow confidenceAT&S significantly raised its revenue and margin guidance, rush orders may increase, long-term agreements lock in capacity, and AI-related high-end substrates have higher prices and gross margins, further validating tightening ABF substrate supply and a price upcycle; however, Unimicron Technology is less likely to benefit than peers due to long-term agreement constraints, slower capacity expansion, and weaker execution.
AuthorsChao Wang、Allen Chang、Al Wang
Target priceNYPCB: NT$2,310; Kinsus: NT$1,125; Unimicron Technology: NT$1,220
CoverageEurope
SubsidiariesPegavision
Business segmentsABF Substrates、BT Substrates、PCB、HDI、FPC
Research firm divisions/subsidiariesGoldman Sachs(Other)、Goldman Sachs (Asia) L.L.C.(Other)、Goldman Sachs (Asia) L.L.C., Taipei Branch(Other)

AI summary card

AT&S Guidance Upgrade Reinforces ABF Shortage and Price-Hike Thesis, with Clearer Benefits for NYPCB and Kinsus

AT&S revenue, margin, and capacity expansion information validates strong AI substrate demand and tightening supply; Goldman Sachs maintains Buy ratings on NYPCB and Kinsus and a Neutral rating on Unimicron Technology.

NYPCB: Buy and on the Conviction List, target price NT$2,310; Kinsus: Buy, target price NT$1,125; Unimicron Technology: Neutral, target price NT$1,220.
ABF SubstratesAI ServersSupply-Demand GapProduct Mix ImprovementPrice IncreaseLong-Term Supply AgreementCapacity Expansion
  • AT&S raised its FY26/27 revenue growth guidance from 30%-35% to 45%-55%, with the midpoint implying approximately EUR2.7bn.
  • AT&S raised its FY26/27 EBITDA margin guidance from 25%-29% to 32%-37%, mainly driven by new customer agreements, incremental orders, and product mix improvement.
  • Goldman Sachs expects the ABF substrate supply shortage ratio to expand from 8% in 2026 to 34% in 2027 and 51% in 2028.
  • AI-related substrate gross margins can exceed 50%, higher than the 30%+ for AT&S's substrate business in FY1Q26/27, suggesting upside to margin forecasts for Taiwan suppliers.
  • Maintain Buy ratings and 12-month target prices of NT$2,310 and NT$1,125 for NYPCB and Kinsus; maintain Neutral rating and NT$1,220 target price for Unimicron Technology.

Report interpretation

Overview

The report uses the FY1Q26/27 earnings call of Austrian PCB and substrate manufacturer AT&S as a reference to assess demand, pricing, capacity, and profitability trends in Taiwan's ABF substrate industry. AT&S significantly raised its full-year revenue and EBITDA margin guidance and said rush orders, long-term customer agreements, and demand for AI-related high-end products may bring further upside. On this basis, Goldman Sachs reiterates its view that ABF substrates entered a price-hike cycle in the first half of 2026 and that the future supply-demand gap will continue to widen.

Core views

First, AT&S's guidance upgrade does not simply come from shipment growth, but is jointly driven by new customer agreements, additional orders, and a better product mix, reflecting higher prices and gross margins for AI-related high-end substrates. Second, rush orders typically carry higher pricing; if orders increase further, industry revenue and margins may continue to exceed expectations. Third, customers are locking in long-term capacity through prepayments and incremental investment; Kulim 1.0 and 2.0 are already fully booked, indicating that high-end capacity beyond 2029 is also being competed for in advance. Fourth, Goldman Sachs expects the ABF substrate supply shortage ratio to expand from 8% in 2026 to 34% in 2027 and 51% in 2028, with price increases and utilization improvement supporting earnings improvement over the next several quarters to years. At the stock level, NYPCB and Kinsus have higher exposure to BT and non-long-term-agreement ABF, giving them stronger pricing flexibility; more than 70% of Unimicron Technology's ABF shipments are covered by long-term agreements, and its capacity expansion and execution are weaker than peers, so it is rated Neutral only.

Analysis framework

The report combines peer operating information read-through, industry supply-demand gap forecasts, product mix and gross margin comparisons, and forward P/E valuation. It first extracts AT&S's revenue, margin, order, and capacity expansion guidance; then compares these with the product mix, long-term agreement coverage, utilization, and earnings forecasts of Taiwan ABF manufacturers; finally, it determines 12-month target prices for the three companies based on expected 2028 P/E and historical upcycle valuation ranges.

Methodology notes

  • Industry AnalysisPeer Operating Information Read-Through

    Using AT&S's guidance, orders, and capacity expansion information to infer cycle changes for Taiwan ABF suppliers

    AT&S and Taiwan manufacturers are in the same PCB and IC substrate value chain. Its rush orders, long-term agreements, and high-end product margins can serve as leading evidence for industry demand, pricing, and capacity tightness.

  • Supply-Demand AnalysisSupply-Demand Gap Model

    Judging the direction of prices, utilization, and margins through the supply shortage ratio

    Goldman Sachs expects the ABF substrate supply shortage ratio to expand from 8% in 2026 to 34% in 2027 and 51% in 2028, and accordingly judges that price increases will accelerate further and industry utilization will continue to rise.

  • Profitability AnalysisProduct Mix and Gross Margin Comparison

    Comparing gross margin levels of AI-related substrates, traditional substrates, and different manufacturers

    AI-related substrates have higher prices and gross margins that can exceed 50%; AT&S's FY26/27 implied gross margin guidance is 41%-46%, above Goldman Sachs's current forecasts of 35%, 30%, and 29% for NYPCB, Kinsus, and Unimicron Technology, indicating potential upside to forecasts for Taiwan manufacturers.

  • Valuation methodsForward P/E Valuation

    Determining 12-month target prices by applying upcycle P/E multiples to expected 2028 earnings

    The NYPCB target price applies a 21x 2028 P/E, Kinsus applies 16.5x, and Unimicron Technology applies 17.4x; these are respectively 1.5, 1.2, and 2.7 standard deviations above their historical upcycle average valuations.

Asset mapping & comparison

Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).

  • NYPCB(8046.TW)
    Key beneficiary of the ABF price-hike cycle
    Strengths
    BT substrates and non-long-term-agreement ABF substrates together contribute more than 70% of revenue, providing relatively high pricing flexibility; the high-end ABF revenue share is expected to rise to above 40% by 2027; expected 2026-2028 earnings CAGR is 122%.
    Weaknesses
    As of the first half of 2025, high-end ABF substrate revenue share was still below 20%, and new high-end capacity needs to complete customer qualification.
    Comparison
    Compared with Unimicron Technology, it is less constrained by long-term agreements and can benefit more directly from spot price increases and rush orders.
    Risks
    PC demand recovery slower than expected, ABF substrate price increases slower than expected, and new high-end capacity qualification slower than expected.
  • Kinsus(3189.TW)
    Beneficiary of the ABF and BT substrate upcycle
    Strengths
    ABF and BT substrate market share was approximately 10% in 2024, with rising high-end ABF market share; about 36% of 2025 revenue comes from BT substrates, and about 30% of ABF revenue comes from non-long-term-agreement customers, providing strong price-hike flexibility.
    Weaknesses
    Approximately 18% of 2025 revenue comes from contact lens subsidiary Pegavision, and non-substrate businesses may affect overall earnings sensitivity.
    Comparison
    Its improving high-end ABF share and non-long-term-agreement exposure make it a greater beneficiary than Unimicron Technology, which has slower capacity expansion and higher agreement coverage.
    Risks
    PC demand recovery slower than expected, ABF substrate price increases slower than expected, and AI server orders below expectations from the second half of 2026 onward.
  • Unimicron Technology(3037.TW)
    Limited beneficiary of industry improvement
    Strengths
    ABF substrate market share was approximately 25% in 2025, giving it significant industry scale; supply-demand improvement helps it pass through raw material costs and improve long-term profitability.
    Weaknesses
    More than 70% of ABF shipments are covered by long-term agreements, limiting price flexibility; execution, production yield, and capacity expansion speed are weaker than peers, and AI-related revenue growth may be slower.
    Comparison
    Although its market share is relatively large, long-term agreements and capacity expansion constraints mean its earnings leverage in this price-hike cycle is lower than NYPCB and Kinsus.
    Risks
    PC demand recovery, ABF upgrade progress, and AI server PCB market share changes could all be faster or slower than expected.
  • AT&S(ATS.VI)
    Reference company for Taiwan ABF industry conditions; not covered in the report
    Strengths
    Revenue and margin guidance were significantly raised, Kulim 1.0 and 2.0 are fully booked, customer long-term agreements provide utilization assurance, and it has technologies such as EMIB-(T).
    Weaknesses
    Capacity expansion requires substantial capital and continues to face constraints in fiberglass raw materials such as E-glass and T-glass.
    Comparison
    Its FY26/27 implied gross margin guidance is above Goldman Sachs's current forecasts for the three Taiwan suppliers, providing a reference for upward earnings revisions for Taiwan manufacturers.
    Risks
    Raw material shortages, capacity ramp-up falling short of expectations, new customer project execution, and risks to fulfillment of long-term agreements.

Key data

  • AT&S FY26/27 revenue growth guidance45% to 55%Previously 30% to 35%, with the midpoint corresponding to revenue of approximately EUR2.7bn; FY25/26 revenue was EUR1.8bn.
  • AT&S FY26/27 EBITDA margin guidance32% to 37%Previously 25% to 29%; FY25/26 actual was 23%.
  • AT&S implied gross margin guidance41% to 46%Higher than Goldman Sachs's gross margin forecasts for the three Taiwan ABF manufacturers from the second quarter of 2026 to the first quarter of 2027.
  • Taiwan ABF manufacturer gross margin forecastsNYPCB 35%; Kinsus 30%; Unimicron Technology 29%The report believes there is still upside versus AT&S's latest guidance.
  • ABF substrate supply shortage ratio2026 8%; 2027 34%; 2028 51%The supply-demand gap is expected to continue widening, supporting upward movement in prices and utilization.
  • AT&S Kulim capacity expansion investmentEUR1.5bn to EUR2.0bnPlans to add one production line for Kulim 1.0 in FY28 and advance Kulim 2.0 for a new large customer in FY29.
  • AI-related substrate gross marginAbove 50%Higher than the 30%+ for AT&S's substrate business in FY1Q26/27.
  • NYPCB earnings growth forecast2026 to 2028 earnings CAGR of 122%Driven by ABF and BT price increases, a higher share of high-end ABF, and tightening industry supply.
  • Kinsus earnings growth forecast2026 to 2029 earnings CAGR of approximately 106%Mainly driven by pricing improvement for BT substrates and non-long-term-agreement ABF substrates.
  • 12-month target pricesNYPCB NT$2,310; Kinsus NT$1,125; Unimicron Technology NT$1,220The report maintains the original target prices and corresponding ratings.

Impact & implications

AT&S's latest information increases the likelihood of upward revisions to earnings forecasts for Taiwan ABF substrate manufacturers. Supply shortages, rush orders, and customer prepayments that lock in capacity will strengthen suppliers' bargaining power, while demand for AI ASIC servers and high-end switching chips is expected to raise the share of high-value products. NYPCB may be a key beneficiary due to its higher revenue share from BT and non-long-term-agreement ABF and faster pricing pass-through; Kinsus combines a higher high-end ABF share with price-hike flexibility in non-long-term-agreement products; while Unimicron Technology can benefit from industry improvement and raw material cost pass-through, its high long-term agreement coverage, slower capacity expansion, and weaker yields limit its relative upside.

Risks

  • PC end demand recovery slower than expected.
  • ABF substrate supply-demand gap or price increase magnitude below expectations.
  • AI server and high-end switching chip orders below expectations.
  • New high-end capacity qualification, capacity expansion, or yield improvement slower than expected.
  • Continued shortages of key fiberglass raw materials such as E-glass and T-glass, pushing up costs.
  • Long-term supply agreements limiting some manufacturers' ability to raise prices.
  • High valuation multiples amplifying share price risk when earnings forecasts are revised down.

What to watch

  • Whether AT&S secures more high-priced rush orders and raises revenue or margin guidance again.
  • Whether the pace of ABF substrate price increases and industry utilization continues to rise in the second half of 2026.
  • Whether supply shortage ratios in 2027 and 2028 evolve toward the forecasts of 34% and 51%.
  • Whether customers continue to lock in capacity beyond 2029 through prepayments or incremental investment.
  • NYPCB's high-end ABF revenue share and progress on customer qualification for new capacity.
  • Kinsus's high-end ABF market share, BT substrate pricing, and changes in AI server orders.
  • Unimicron Technology's yield, capacity expansion speed, and AI server PCB market share.
  • E-glass and T-glass supply conditions and whether raw material costs can be smoothly passed through.
Zhejiang ICP No. 2022035445-5
Disclaimer: Market data, charts, indicators, research views, and other information provided on this website are intended solely for information display, research communication, and educational reference. They should not be regarded as personalized investment advice, securities recommendations, trading instructions, solicitations, or guarantees of return. While we strive to improve the reliability of our data and content, such information may still be subject to delays, errors, incompleteness, or untimely updates due to source differences, methodological limitations, system processing, or market volatility. Users should exercise independent judgment based on their own circumstances and bear all risks and responsibilities arising from the use of this website.

Settings

Sign in to view recent logins